Skip to main content
. Author manuscript; available in PMC: 2018 Dec 15.
Published in final edited form as: Pediatr Res. 2018 Jun 1;84(5):619–624. doi: 10.1038/s41390-018-0070-4

Table 2.

Prevalence of wheezing outcome over the three-year study period.

Study Visit Number of participants who responded to questions pertaining to the wheezing outcome on the INSPIRE questionnaire* Number of wheezing episodes
No Wheezing Episodes n (%) 1–3 Wheezing Episodes n (%) 4–12 Wheezing Episodes n (%) >12 Wheezing Episodes n (%)
Year 1 1,761 1,291 (73.3%) 353 (20.1%) 85 (4.8%) 32 (1.8%)
Year 2 1,673 1,278 (76.4%) 293 (17.5%) 84 (5.0%) 18 (1.1%)
Year 3 1,340 1,063 (79.3%) 211 (15.8%) 55 (4.1%) 11 (0.8%)
*

Among the 97% of infants in whom the newborn metabolic screening data were linked.